Innate immune responses to systemic acinetobacter baumannii infection in mice: Neutrophils, but not interleukin-17, mediate host resistance

Infection and Immunity

Volumn 79, Issue 8, 2011, Pages 3317-3327

  Breslow, Jessica M ^a,b   Meissler Jr , Joseph ^a   Hartzell, Rebecca R ^a   Spence, Phillip B ^a   Truant, Allan ^a   Gaughan, John ^a   Eisenstein, Toby K ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CXCL1 CHEMOKINE; INTERLEUKIN 17; INTERLEUKIN 8;

ACINETOBACTER INFECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; HOST RESISTANCE; INNATE IMMUNITY; LUNG; MALE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL CAVITY; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; SPLEEN; WILD TYPE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANIMAL STRUCTURES; ANIMALS; BACTERIAL LOAD; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-17; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NEUTROPHILS; SEPSIS; TIME FACTORS; VIRULENCE;

EID: 79961101463     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00069-11     Document Type: Article

References (63)

1. Beceiro, A., et al. 2009. In vitro activity and in vivo efficacy of clavulanic acid against Acinetobacter baumannii. Antimicrob. Agents Chemother. 53:4298-4304.
2. Bernabeu-Wittel, M., et al. 2005. Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia. Clin. Microbiol. Infect. 11:319-325.
3. Brown, C. R., V. A. Blaho, and C. M. Loiacono. 2003. Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattrac-tant protein-1 production in joints and requires neutrophil recruitment via CXCR2. J. Immunol. 171:893-901.
4. Brown, H. J., et al. 2007. Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J. Am. Soc. Nephrol. 18:1732-1739.
5. Centers for Disease Control and Prevention. 2004. Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR Morb. Mortal. Wkly. Rep. 53:1063-1066.
6. Chiang, S. R., et al. 2009. Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii. Crit. Care Med. 37:2590-2595.
7. Crandon, J. L., A. Kim, and D. P. Nicolau. 2009. Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs. J. Antimicrob. Chemother. 64:837-839.
8. da Silva, J. B., et al. 2009. Chemokines expression during Leptospira interrogans serovar Copenhageni infection in resistant BALB/c and susceptible C3H/HeJ mice. Microb. Pathog. 47:87-93.
9. Erridge, C., O. L. Moncayo-Nieto, R. Morgan, M. Young, and I. R. Poxton. 2007. Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling. J. Med. Microbiol. 56:165-171.
10. Frink, M., et al. 2007. Keratinocyte-derived chemokine plays a critical role in the induction of systemic inflammation and tissue damage after traumahemorrhage. Shock 28:576-581.
11. Gaynes, R., and J. R. Edwards. 2005. Overview of nosocomial infections caused by gram-negative bacilli. Clin. Infect. Dis. 41:848-854.
12. Gordon, N. C., and D. W. Wareham. 2010. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int. J. Antimicrob. Agents 35:219-226.
13. Happel, K. I., et al. 2005. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202:761-769.
14. Happel, K. I., et al. 2003. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170:4432-4436.
15. Huang, W., P. L. Fidel, and P. Schwarzenberger. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190:624-631.
16. Jacobs, A. C., et al. 2010. Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis. Infect. Immun. 78:1952-1962.
17. Joly-Guillou, M.-L., M. Wolff, J.-J. Pocidalo, F. Walker, and C. Carbon. 1997. Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibioic effect of imipenem. Antimicrob. Agents Chemother. 41:345-351.
18. Joly-Guillou, M. L., M. Wolff, R. Farinotti, A. Bryskier, and C. Carbon. 2000. In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia. J. Antimicrob. Chemother. 46:827-830.
19. Knapp, S., et al. 2006. Differential roles of CD14 and Toll-like receptors 4 and 2 in murine Acinetobacter pneumonia. Am. J. Respir. Crit. Care Med. 173:122-129.
20. Ko, W. C., et al. 2004. In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain. J. Antimicrob. Chemother. 53:393-395.
21. Kohyama, S., et al. 2007. IL-23 enhances host defense against vaccinia virus infection via a mechanism party involving IL-17. J. Immunol. 179:3917-3925.
22. Koomanachai, P., A. Kim, and D. P. Nicolau. 2009. Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model. J. Antimicrob. Chemother. 63:982-987.
23. Langrish, C. L., et al. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201:233-240.
24. Lomas-Neira, J., et al. 2005. Divergent roles of murine neutrophil chemokines in hemorrhage induced priming for acute lung injury. Cytokine 31: 169-179.
25. Luke, N. R., et al. 2010. Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis. Infect. Immun. 78:2017-2023.
26. Ma, J., et al. 2010. Morphine disrupts interleukin-23 (IL-23)/IL-17-mediated pulmonary mucosal host defense against Streptococcus pneumoniae infection. Infect. Immun. 78:830-837.
27. Montero, A., et al. 2004. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. J. Antimicrob. Chemother. 54:1085-1091.
28. Montero, A., et al. 2002. Efficacy of colistin versus -lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 46:1946-1952.
29. Murray, C. K., et al. 2006. Bacteriology of war wounds at the time of injury. Mil. Med. 171:826-831.
30. Nakae, S., et al. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17:375-387.
31. Obana, Y. 1986. Pathogenic significance of Acinetobacter calcoaceticus: analysis of experimental infection in mice. Microbiol. Immunol. 30:645-657.
32. Obana, Y., T. Nishino, and T. Tanino. 1985. In-vitro and in-vivo activities of antimicrobial agents against Acinetobacter calcoaceticus. J. Antimicrob. Chemother. 15:580-587.
33. Pachon-Ibanez, M. E., et al. 2010. Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models caused by imipenem-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 54:1165-1172.
34. Pantopoulou, A., et al. 2007. Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin. Int. J. Antimicrob. Agents 29:51-55.
35. Peleg, A. Y., H. Seifer, and D. L. Paterson. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582.
36. Qiu, H., R. KuoLee, G. Harris, and W. Chen. 2009. High susceptibility to respiratory Acinetobacter baumannii infection in A/J. mice is associated with a delay in early pulmonary recruitment of neutrophils. Microbes Infect. 11:946-955.
37. Qiu, H., R. KuoLee, G. Harris, and W. Chen. 2009. Role of NADPH phagocyte oxidase in host defense against acute respiratory Acintobacter baumannii infection in mice. Infect. Immun. 77:1015-1023.
38. Renckens, R., et al. 2006. The acute-phase response and serum amyloid A inhibit the inflammatory response to Acinetobacter baumannii pneumonia. J. Infect. Dis. 193:187-195.
39. Rodriguez-Hernandez, M. J., et al. 2000. Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia. J. Antimicrob. Chemother. 45:493-501.
40. Rudner, X. L., K. I. Happel, E. A. Young, and J. E. Shellito. 2007. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumoncystis carinii infection. Infect. Immun. 75:3055-3061.
41. Russo, T. A., et al. 2010. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect. Immun. 78: 3993-4000.
42. Russo, T. A., et al. 2009. Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo. J. Infect. Dis. 199: 513-521.
43. Russo, T. A., et al. 2008. Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology. Infect. Immun. 76:3577-3586.
44. Rutitzky, L. I., J. R. Lopes da Rosa, and M. J. Stadecker. 2005. Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J. Immunol. 175:3920-3926.
45. Schultz, M. J., et al. 2002. Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:L285-L290.
46. Scott, P., et al. 2007. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin. Infect. Dis. 44:1577-1584.
47. Shibata, K., H. Yamada, H. Hara, K. Kishihara, and Y. Yoshikai. 2007. Resident Vdelta1α gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178: 4466-4472.
48. Smith, M. W., J. E. Schmidt, J. E. Rehg, C. J. Orihuela, and J. A. McCullers. 2007. Induction of pro-and anti-inflammatory molecules in a mouse model of Pneumococcal pneumonia after influenza. Comp. Med. 57:82-89.
49. Song, J. Y., H. J. Cheong, J. Lee, A. K. Sung, and W. J. Kim. 2009. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model. Int. J. Antimicrob. Agents 33:33-39.
50. Spehlmann, M. E., et al. 2009. CXCR2-dependent mucosal neutrophil influx protects against colitis-associated diarrhea caused by an attaching/effacing lesion-forming bacterial pathogen. J. Immunol. 183:3332-3343.
51. Tiesset, H., et al. 2009. Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro-and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection. J. Nutr. 139:82-89.
52. Towner, K. J. 2009. Acinetobacter: an old friend but a new enemy. J. Hosp. Infect. 73:355-363.
53. van der Zee, M., et al. 2010. Synthetic human chorionic gonadotropin-related oligopeptides impair early innate immune responses to Listeria monocytogenes in mice. J. Infect. Dis. 201:1072-1080.
54. van Faassen, H., et al. 2007. Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice. Infect. Immun. 75:5597-5608.
55. Wang, Y., et al. 2010. Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection. Immunity 32:403-413.
56. Wilkinson, T. S., et al. 2009. Trappin-2 promotes early clearance of Pseudomonas aeruginosa through CD14-dependent macrophage activation and neutrophil recruitment. Am. J. Pathol. 174:1338-1346.
57. Wisplinghoff, H., et al. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.
58. Witowski, J., K. Ksiazek, and A. Jörres. 2004. Interleukin-17: a mediator of inflammatory responses. Cell. Mol. Life Sci. 61:567-579.
59. Wolff, M., M.-L. Joly-Guillou, R. Farinotti, and C. Carbon. 1999. In vivo efficacies of combinations of -lactams, -lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model. Antimicrob. Agents Chemother. 43:1406-1411.
60. Wu, Q., et al. 2007. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect. 9:78-86.
61. Ye, P., et al. 2001. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell Mol. Biol. 25:335-340.
62. Ye, P., et al. 2001. Requirement of Interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194:519-527.
63. Zhou, X., et al. 2009. Critical role of interleukin-17/interleukin-17 receptor axis in regulating host susceptibility to respiratory infection with Chlamydia species. Infect. Immun. 77:5059-5070.